108 related articles for article (PubMed ID: 6594532)
21. [Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
Tsurusawa M; Katano N; Hirota T; Ito M; Yanase T; Asami K; Koizumi S; Nakayama M; Miyawaki T; Suzumiya J; Nishikawa K; Mugisima H; Horikoshi Y; Hatae Y; Iwai A; Anami K; Kikuchi M; Osima K; Kaneko Y; Kataoka S; Tanaka A; Chin M; Taga T; Watanabe A; Fujimoto T
Rinsho Ketsueki; 1998 Nov; 39(11):1092-8. PubMed ID: 9866420
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic results in 22 cases of childhood non-Hodgkin's lymphoma treated by ACOP combination chemotherapy].
Imashuku S; Arakawa S; Todo S; Esumi N; Shimizu Y; Fujiwara F; Tsunamoto K; Morioka Y; Sugimoto T; Fushiki S
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1086-93. PubMed ID: 3566305
[TBL] [Abstract][Full Text] [Related]
23. [Patterns of relapse in non-Hodgkin's lymphoma after complete remission induced by combination chemotherapy].
Yamazaki H; Kuraishi Y; Takasaki N; Ozeki H; Mashizu N; Nagamine D; Usui N; Nakamura T; Aiba K; Yokoyama K
Rinsho Ketsueki; 1985 Dec; 26(12):1936-41. PubMed ID: 2422407
[No Abstract] [Full Text] [Related]
24. [Myelotoxicity due to cancer chemotherapy with special reference to autologous bone marrow transplantation].
Nakamura S
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1195-202. PubMed ID: 6381786
[TBL] [Abstract][Full Text] [Related]
25. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
Bassan R; Pogliani E; Lerede T; Fabris P; Rossi G; Morandi S; Casula P; Lambertenghi-Deliliers G; Vespignani M; Izzi T; Coser P; Corneo G; Barbui T
Haematologica; 1999 Dec; 84(12):1088-93. PubMed ID: 10586210
[TBL] [Abstract][Full Text] [Related]
26. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
27. [Acute myeloid leukemia after treatment of Hodgkin's disease].
Carneiro PC; Pereira ED; Mitteldorf CS; Martinez GA; Beitler B; Pozzi DH
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):87-90. PubMed ID: 2616992
[TBL] [Abstract][Full Text] [Related]
28. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
29. Poor prognosis non-Hodgkin's lymphoma in the elderly: clinical presentation and management.
Mead GM; Macbeth FR; Williams CJ; Ryall RD; Wright DH; Whitehouse JM
Q J Med; 1984; 53(211):381-90. PubMed ID: 6548316
[TBL] [Abstract][Full Text] [Related]
30. [Chemotherapy in advanced non-Hodgkin's lymphoma: follow-up studies].
Kimura I
Nihon Rinsho; 1983 Nov; 41(11):2600-10. PubMed ID: 6200629
[No Abstract] [Full Text] [Related]
31. [Epirubicin-based combination chemotherapy in the treatment of non-Hodgkin's lymphoma: with emphasis of elderly patients].
Sampi K; Takouda K; Hattori M
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1925-8. PubMed ID: 2393310
[TBL] [Abstract][Full Text] [Related]
32. [Follicular lymphoma in two brothers].
Asahi A; Okamoto S; Matsushita H; Hattori Y; Takayama N; Ikeda Y
Rinsho Ketsueki; 2001 May; 42(5):408-13. PubMed ID: 11452461
[TBL] [Abstract][Full Text] [Related]
33. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
[TBL] [Abstract][Full Text] [Related]
34. Treatment of childhood acute lymphoblastic leukemia with protocol TCL821: a report of Taiwan Children's Cancer Study Group.
Taiwan Yi Xue Hui Za Zhi; 1989 Jan; 88(1):48-56. PubMed ID: 2666568
[TBL] [Abstract][Full Text] [Related]
35. [Alternating chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP); etoposide, procarbazine, vindesine and prednisolone (EPVP) as a treatment for advanced-stage Hodgkin's disease].
Kumagai K; Takagi T; Sakai C; Wakatsuki S
Gan To Kagaku Ryoho; 1996 Mar; 23(4):499-501. PubMed ID: 8678506
[No Abstract] [Full Text] [Related]
36. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
[TBL] [Abstract][Full Text] [Related]
37. [Results of modified LSA2-L2 protocol with moderate-dose MTX therapy in children with untreated non-Hodgkin's lymphoma].
Shimamoto Y; Imai S; Endo N
Gan To Kagaku Ryoho; 1992 Mar; 19(3):395-8. PubMed ID: 1543367
[No Abstract] [Full Text] [Related]
38. [Non-Hodgkin's lymphoma with Toxoplasma encephalitis].
Yoshimura K; Hara T; Tsurumi H; Goto H; Tajika M; Fukutomi Y; Murakami N; Moriwaki H
Rinsho Ketsueki; 1999 Jul; 40(7):563-7. PubMed ID: 10483139
[TBL] [Abstract][Full Text] [Related]
39. [Therapeutic results of DCMP therapy (2M-80) in acute non-lymphocytic leukemia--the relationship between the residual leukemic cells and duration of remission].
Moriyama Y; Urushiyama M; Ohnishi M; Koyama S; Hirosawa H; Hanano M; Fuse I; Takai K; Nagayama R; Fujiwara M; Kishi K; Takahashi M; Koike T; Sakai C; Kashimura M; Miura R; Aoyagi A; Sanada M; Hattori A; Shibata A; Shinada S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1549-54. PubMed ID: 6892201
[TBL] [Abstract][Full Text] [Related]
40. Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.
Waits TM; Greco FA; Greer JP; Johnson DH; Wolff SN; Stein RS; McMaster ML; Hainsworth JD
J Clin Oncol; 1993 May; 11(5):943-9. PubMed ID: 7683712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]